Johnson & Johnson’s one-dose COVID vaccine promising in early trial
NHS Race and Health Observatory appoints global experts on inequalities to its board
14 January 2021Machine learning tool gives early warning of cardiac issues in COVID-19 patients
14 January 2021Johnson & Johnson’s one-dose COVID vaccine promising in early trial
A single-shot COVID-19 vaccine from Johnson & Johnson has shown very strong results in early clinical trials, potentially providing a significant boost to U.S. vaccination efforts.
